Acamprosate: Indication, Dosage, Side Effect, Precaution

Generic Medicine Info Full Generic Medicine Info

Dosage/Direction for Use Administration Contraindications Special Precautions Adverse Reactions Pregnancy Category (US FDA) Overdosage Drug Interactions Food Interaction Action Storage CIMS Class ATC Classification

This information is not country-specific. Please refer to the India prescribing information.

Generic Medicine Info

Administration

May be taken with or without food. Swallow whole & do not chew/crush/cut. Consult product literature for specific recommendations.

Contraindications

Severe renal impairment (CrCl <30 mL/min).

Special Precautions

Patient with suicidal ideation. Moderate renal impairment (CrCl 30-50 mL/min) and severe hepatic impairment (Child-Pugh class C). Elderly. Pregnancy and lactation. Patient Counselling This drug may cause CNS depression, if affected, do not drive or operate machinery. Monitoring Parameters Monitor renal function and weight. Assess for signs of suicidal ideation.

Adverse Reactions

Significant: CNS depression; suicidal thinking or behaviour. Gastrointestinal disorders: Nausea, vomiting, diarrhoea, abdominal pain, flatulence. Reproductive system and breast disorders: Frigidity, impotence. Skin and subcutaneous tissue disorders: Pruritus, maculopapular rash.

Pregnancy Category (US FDA)

Drug Interactions

Increased plasma concentration with naltrexone.

CIMS Class

Antidotes, Detoxifying Agents & Drugs Used in Substance Dependence

ATC Classification

N07BB03 - acamprosate ; Belongs to the class of drugs used in the management of alcohol dependence.

Disclaimer: This information is independently developed by CIMS based on acamprosate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com